Variant report
Variant | nsv877595 |
---|---|
Chromosome Location | chr3:144979382-145066106 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:14)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:14 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:145011656..145013483-chr3:145013706..145015700,2 | MCF-7 | breast: | |
2 | chr3:144984069..144984806-chr3:145485343..145486312,4 | MCF-7 | breast: | |
3 | chr3:145011656..145013483-chr3:145013706..145015700,2 | MCF-7 | breast: | |
4 | chr3:145021934..145024791-chr3:145028136..145030465,2 | K562 | blood: | |
5 | chr3:144983996..144984506-chr3:145485486..145486139,2 | MCF-7 | breast: | |
6 | chr3:145006504..145009118-chr3:145011068..145013301,2 | MCF-7 | breast: | |
7 | chr3:145047302..145049061-chr3:145051775..145054184,2 | K562 | blood: | |
8 | chr3:145061451..145063891-chr3:145082446..145084868,2 | K562 | blood: | |
9 | chr3:144983651..144984522-chr3:145123095..145123660,2 | MCF-7 | breast: | |
10 | chr3:145047302..145049061-chr3:145051775..145054184,2 | K562 | blood: | |
11 | chr3:145021934..145024791-chr3:145028136..145030465,2 | K562 | blood: | |
12 | chr3:145063874..145066771-chr3:145068629..145070450,2 | K562 | blood: | |
13 | chr3:145006504..145009118-chr3:145011068..145013301,2 | MCF-7 | breast: | |
14 | chr3:144984029..144984834-chr3:145416240..145416755,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375240128 | chr3:144990456-144990457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116059907 | chr3:144990461-144990462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116247373 | chr3:144990462-144990463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371484270 | chr3:144990466-144990467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527980587 | chr3:144990522-144990523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs66679830 | chr3:144990524-144990525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs570860496 | chr3:144990531-144990532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537930897 | chr3:144990557-144990558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550221642 | chr3:144990560-144990561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189485512 | chr3:145005094-145005095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528093022 | chr3:145005095-145005096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546682893 | chr3:145005100-145005101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558179028 | chr3:145005118-145005119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551712913 | chr3:145005128-145005129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181179036 | chr3:145005133-145005134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371905335 | chr3:145005152-145005153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142775077 | chr3:145005176-145005177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377627113 | chr3:145005178-145005179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527883215 | chr3:145021400-145021401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552523422 | chr3:145021446-145021447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187951980 | chr3:145021474-145021475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538503702 | chr3:145021475-145021476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550515046 | chr3:145021492-145021493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568415258 | chr3:145021507-145021508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543856972 | chr3:145021550-145021551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554239723 | chr3:145021572-145021573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536489028 | chr3:145027246-145027247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146726024 | chr3:145027258-145027259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193154827 | chr3:145027271-145027272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534170304 | chr3:145027278-145027279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184733031 | chr3:145027284-145027285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140318740 | chr3:145027322-145027323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566249223 | chr3:145027408-145027409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538293655 | chr3:145027409-145027410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556391135 | chr3:145027419-145027420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7652254 | chr3:145027435-145027436 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs541703263 | chr3:145027445-145027446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560371088 | chr3:145027447-145027448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs386666703 | chr3:145027448-145027449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200992393 | chr3:145027449-145027450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs36110028 | chr3:145027450-145027451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62274803 | chr3:145027480-145027481 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs144170398 | chr3:145027509-145027510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543107533 | chr3:145027578-145027579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79879163 | chr3:145031823-145031824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554377867 | chr3:145031828-145031829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370962675 | chr3:145031834-145031835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564230382 | chr3:145031857-145031858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567512474 | chr3:145031891-145031892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538031966 | chr3:145031895-145031896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:144990400-144990600 | Enhancers | HSMM | muscle |
2 | chr3:145005000-145005200 | Enhancers | GM12878-XiMat | blood |
3 | chr3:145021400-145021600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:145027200-145027600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr3:145031800-145032200 | Enhancers | Fetal Kidney | kidney |
6 | chr3:145033000-145033800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr3:145033200-145033600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr3:145033200-145034800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr3:145033400-145033800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr3:145033400-145034400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr3:145038800-145039200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr3:145050400-145050800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr3:145050600-145051000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
14 | chr3:145050600-145051000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr3:145051000-145052000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
16 | chr3:145052000-145054800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
17 | chr3:145054800-145070200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr3:145059600-145066000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
19 | chr3:145066000-145066200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr3:145066000-145066200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
21 | chr3:145066000-145066200 | ZNF genes & repeats | Pancreas | Pancrea |